Resource data sheet
Prev.
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pGL3-AID R1+R4 full

Reporter construct of mouse Aicda locus, position -9226 to -7585 plus -1527 to +101.

Catalog number RDB07880
Resource name pGL3-AID R1+R4 full
Clone info. Reporter construct of mouse Aicda locus with firefly luciferase. Cloned position, -9226 to -7585 plus -1527 to +101.
Comment Nat. Immunol. (2010) 2, 148-154, Fig. 1b.
Vector backbone pGL3 (Plasmid)
Selectable markers Amp^r
Gene/insert name Mouse Aicda genomic DNA
Depositor|Developer Honjo, Tasuku |
Other clones in our bank

External Database
Mouse Aicda

          Reference sequence
            

          Distribution information

          Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
          Terms and conditions set forth by the DEPOSITOR In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of literature(s) designated by the DEPOSITOR is requested. (Nat. Immunol., 11, 148-154 (2010)). In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE.
          Additional terms and conditions for distribution The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation.
          Ordering Please visit Information of Request for Distribution.[link] 
          Order form 
          [Credit Card Payment]  [Bank Transfer Payment]
          Material Transfer Agreement (MTA for use for not-for-profit academic purpose) [Word]
          提供案内 (日本国内) [open/close]

          提供条件 利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する (Nat. Immunol., 11, 148-154 (2010))。 利用者は、研究成果の公表にあたって謝辞の表明を必要とする。 学術機関の学術研究に限る。 営利機関の利用希望者は、事前に利用条件等につき寄託者と合意し、提供承諾を得ること。 利用者が本件リソースを使用して得られた研究成果に基づき特許等の申請、及び事業活動を行う場合は、寄託者と別途協議を行う。
          付加的提供条件 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。
          提供依頼 手続きの詳細は、「提供申込みについて[link]」をご覧ください。
          提供依頼書 [Word]
          提供同意書 (MTA、非営利機関による非営利学術研究用)[Word]

          Catalog # Resource name Shipping form Fee (non-profit org.)
          RDB07880 pGL3-AID R1+R4 full DNA solution

          Please review the QC test results indicated by check icon below as well as clone information before placing your order.

          References and tips

          Electronic file

          Original reference

          original Tran, T.H., B cell-specific and stimulation-responsive enhancers derepress Aicda by overcoming the effects of silencers. Nat. Immunol., 11, 148-154 (2010). PMID 19966806.

          Further references such as user reports and related articles (go to bottom)

          Featured content


          Sequence information

          RIKEN BRC has sequenced portions of this material for quality test.
          Please review the QC test results indicated by check icon as well as clone information before placing your order.

          Test sheet RDB07880_A3Af.pdf check

          Nucleotide sequence of a portion of this resource (if available).

          Primer: pGL3_RV3
          Sequence file: RDB07880_A3Afa.seq check
          >7880_7880_A3Af_pGL3-Rv3_E02_14.ab1
              1 GGTTAGGGGC AGACATTTCT CTATCGATAG GTACCCACCA CTCTCGGCTG TTCTGGAACT
             61 CTCTGTAACC TCGGGCTGTA TGAGTGTATG TGAGTGTGTG TATATGGGTG TGGGGGGGGT
            121 GAGAGTATAT GAGTGTATGT GAGTGTGTAT GTATGGGTGT GAGGTGTGTG TGTGTATGAG
            181 TGTGTGTATG AGTGTGTGTA TGAGTGTGTG TGAGTGTGTG TATATGGGGG GGTGACCCCC
            241 GATGCTTTCC AGAGACCGCC AGCCCCTCAT GCTGGCCATA ACGAAACCTC ACCTGTGTGT
            301 CTCATAGGGA AAGCGAGGTG GTGAACTCCA GATGTCCAAA ACTCAGCTCA GCCGCAGGCG
            361 ACTCGATTTC CAAGTCACAG TATTTTTGGT TAAAAACAAT GTGACCAAGT TGGCTTGTGG
            421 TTTTTCAATA GAAGTTAATG AGGGGAAAGA GAAGTTAATG AAGAAAATAA AAGTTGATCA
            481 AAACCCTGTA AACTGCTTTG CCGCTGTACC AGTTCCAAAT TTCCCGGGAC TGGAAAATGG
            541 TTTTTGTAAC TAAGTGAGAT CTCTTTCCTT CCTTTAGAAG AAGGCAAATG ATAGAATTTG
            601 GCTTTCTTAC AAATCAAGGG TTTTGTATTT GTTCCTATGG CATGTGTACG GCATCTGTAA
            661 GAGAGGGTGT GGGCGTGCGT GTGCGTGTGC TACAGCTCGA GGTGTCTCCA GTATGTCATT
            721 CCCTGGACTA TTGGTCCAAA GTAGGGCAAA GGTCCGAGCC CTCATCCTGT GAGAACAAGT
            781 TAAAAGGGAC TTGTCCCACC CCACCACCCT GGGGGTTCCC CTTAACCCTG TAATGTCCAC
            841 GGGCTGGGTG CTGGGTTTCT TCCCGGTGCC CTGAAATTTT TTATTCCAAG AATTCATTAA
          901 TTCACTTA
          //
          Primer: pGL3_RV6R
          Sequence file: RDB07880_A3Afb.seq check
          >7880_7880_A3Af_pGL3-Rv6R_F02_17.ab1
              1 GTATCCGTCA GCGGATAGAT GGCGCCGGGC CTTTCTTTAT GTTTTTGGCG TCTTCCATGG
             61 ATCGGTCTCC AGCGTGACTT TCTTGACTCC CTCAAAGTCT TAGGCCAAAG GAAGCTTGCT
            121 TCAAGCAAGG CTGCTTCAGT GCTGTTGTGT GACAGAGCAC TGGCCCCTGG CATTCAAATC
            181 TGAGCTTGCT CTTGTGGGCT CCTCCCCCAC GACAGCATCA CTACCACCAG GTATCCAACA
            241 TCTGCCTCCT GGGTTGGGTC CAGTAAAGAT GGGCGGGGCT GTGGTGGGCA AAGCCACACG
            301 GATTAAATGA TTGGGGGGGG GGGCCAGTTC TGCTCATGCT TAATGTCCAA CTTCCTTCGA
            361 GGCTGTTCCT CTAAAAAGCC AGCCCAGGTA TCACAGGTAA CAAAGATCAG GAGACAATAG
            421 CACTGGACAC TTCTCACATT GGTATCATGA TAATGAGCTC TGTGAGTGTG TGTGTGTGTG
            481 TGTGTGTGTG GTCCCGGGTA TCACACCTAA GGTCTGTGCA TACTTCCTAA TTTTAAAACT
            541 ATGATAACAA GAATGATAGC AGTCATAGTG ACTTAAAGTG GCCTTAAATG GCACTTCAGT
            601 TGCATCTTGT GCTTCTTGAA CTTACAGTAT CTGTTCCTTC CGTTTGTTAC ACTCAGTTTT
            661 ATGCCTCAGT AGAGATGGGG GTTGACCACC ACAGCATCCA GAGAGTGAAC TTTAGCCTCC
            721 CAATTCTCTA ATATATTTTT CTTTTTTTTA AAATGACATT ATAAGATAGC TAGAAAGACT
            781 AGTTGCTTGC ACCAAAAAGT GATTTATTTT AATTTTGTGT GTGTGTGTGT GTCAAAAGTA
            841 TTAAAAAAAA AAAAGAACTC CTTTTCCTCA TTAAAAATAC CTTACTGGGA GGCCTGGAGA
            901 GCTGGCCCAG TGATTTAGAG CACTTTACTT CTTATTGGCA GAGACAGCAG CAGTGAAGGC
            961 ACAATGTGTG CTGCTGGATC TGACCTTGAT CATCTGAGAA CATCGTTGGC TTCCTTCCTT
          1021 CTCGTCGTCG TACTACTACT ACTCATACAT ACATCTCTTA CCCGCAGTGC TA
          //

          Please visit Sequencing and PCR primers for primer information.


          References

          Original, user report and related articles

          original Tran, T.H., B cell-specific and stimulation-responsive enhancers derepress Aicda by overcoming the effects of silencers. Nat. Immunol., 11, 148-154 (2010). PMID 19966806.

          2022.05.17

          GNP_filter3_RDBDEP_html_220516.pl